Insider · CIK 0001216626

GOLDBY STEVEN D

Reports to the SEC for 5 companies · PALO ALTO, CA

sec.gov

Transactions

Companies

Filings

CIK

0001216626

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2019-05-23	LFCRLIFECORE BIOMEDICAL, INC. \DE\M Exercise/Conversion	Director	MExercise/Conversion	+4,240 sh	$9.35	+$39.6K	73,137
2019-05-23	LFCRLIFECORE BIOMEDICAL, INC. \DE\M Exercise/Conversion	Director	MExercise/Conversion	+4,240 sh	—	—	73,137
2019-05-23	LFCRLIFECORE BIOMEDICAL, INC. \DE\ · Restricted Stock UnitM Exercise/Conversion	Director	MExercise/Conversion	−4,240 sh	—	—	0
2019-05-23	LFCRLIFECORE BIOMEDICAL, INC. \DE\ · Restricted Stock UnitM Exercise/Conversion	Director	MExercise/Conversion	−4,240 sh	—	—	0
2019-02-28	LFCRLIFECORE BIOMEDICAL, INC. \DE\F Tax Payment	Director	FTax Payment	−2,593 sh	$12.84	−$33.3K	68,897
2019-02-28	LFCRLIFECORE BIOMEDICAL, INC. \DE\ · Nonstatutory Stock Option (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	−5,000 sh	—	—	5,000
2019-02-28	LFCRLIFECORE BIOMEDICAL, INC. \DE\M Exercise/Conversion	Director	MExercise/Conversion	+5,000 sh	$6.66	+$33.3K	71,490
2019-01-08	LFCRLIFECORE BIOMEDICAL, INC. \DE\P Purchase	Director	PPurchase	+20K sh	$11.24	+$225K	66,490
2018-05-30	LFCRLIFECORE BIOMEDICAL, INC. \DE\ · Right to Buy Restricted Stock Unit (RSU)M Exercise/Conversion	Director	MExercise/Conversion	+4,240 sh	—	—	4,240
2018-05-23	LFCRLIFECORE BIOMEDICAL, INC. \DE\M Exercise/Conversion	Director	MExercise/Conversion	+4,286 sh	$13.65	+$58.5K	46,490
2018-05-23	LFCRLIFECORE BIOMEDICAL, INC. \DE\ · Restricted Stock UnitM Exercise/Conversion	Director	MExercise/Conversion	−4,286 sh	—	—	0
2018-02-23	LFCRLIFECORE BIOMEDICAL, INC. \DE\M Exercise/Conversion	Director	MExercise/Conversion	+5,000 sh	$5.77	+$28.8K	44,373
2018-02-23	LFCRLIFECORE BIOMEDICAL, INC. \DE\F Tax Payment	Director	FTax Payment	−2,169 sh	$13.30	−$28.8K	42,204
2018-02-23	LFCRLIFECORE BIOMEDICAL, INC. \DE\ · Nonstatutory Stock Option (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	−5,000 sh	—	—	5,000
2017-06-01	LFCRLIFECORE BIOMEDICAL, INC. \DE\ · Right to Buy Restricted Stock Unit (RSU)M Exercise/Conversion	Director	MExercise/Conversion	+4,286 sh	—	—	4,286
2017-05-25	LFCRLIFECORE BIOMEDICAL, INC. \DE\M Exercise/Conversion	Director	MExercise/Conversion	+5,282 sh	$13.50	+$71.3K	39,373
2017-05-25	LFCRLIFECORE BIOMEDICAL, INC. \DE\ · Restricted Stock UnitM Exercise/Conversion	Director	MExercise/Conversion	−5,282 sh	—	—	0
2017-05-23	LFCRLIFECORE BIOMEDICAL, INC. \DE\ · Nonstatutory Stock Option (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	−5,000 sh	—	—	10,000
2017-05-23	LFCRLIFECORE BIOMEDICAL, INC. \DE\F Tax Payment	Director	FTax Payment	−2,100 sh	$13.40	−$28.1K	34,091
2017-05-23	LFCRLIFECORE BIOMEDICAL, INC. \DE\M Exercise/Conversion	Director	MExercise/Conversion	+5,000 sh	$5.63	+$28.2K	36,191
2016-05-28	LFCRLIFECORE BIOMEDICAL, INC. \DE\ · Restricted Stock UnitM Exercise/Conversion	Director	MExercise/Conversion	−3,475 sh	—	—	0
2016-05-28	LFCRLIFECORE BIOMEDICAL, INC. \DE\M Exercise/Conversion	Director	MExercise/Conversion	+3,475 sh	$11.46	+$39.8K	31,191
2016-05-26	LFCRLIFECORE BIOMEDICAL, INC. \DE\ · Right to Buy Restricted Stock Unit (RSU)M Exercise/Conversion	Director	MExercise/Conversion	+5,222 sh	—	—	5,222
2016-05-25	LFCRLIFECORE BIOMEDICAL, INC. \DE\ · Right to Buy Restricted Stock Unit (RSU)M Exercise/Conversion	Director	MExercise/Conversion	+5,282 sh	—	—	5,282
2015-10-21	LFCRLIFECORE BIOMEDICAL, INC. \DE\F Tax Payment	Director	FTax Payment	+10K sh	$6.72	+$67.2K	27,716
2015-10-21	LFCRLIFECORE BIOMEDICAL, INC. \DE\ · Non Qualified Stock Option (Right to Buy)X Exercise of In-Money	Director	XExercise of In-Money	−10K sh	$6.72	−$67.2K	0
2015-05-29	LFCRLIFECORE BIOMEDICAL, INC. \DE\M Exercise/Conversion	Director	MExercise/Conversion	+4,219 sh	$14.29	+$60.3K	17,716
2015-05-29	LFCRLIFECORE BIOMEDICAL, INC. \DE\ · Restricted Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	−4,219 sh	—	—	0
2015-05-28	LFCRLIFECORE BIOMEDICAL, INC. \DE\ · Right to Buy Restricted Stock Unit (RSU)M Exercise/Conversion	Director	MExercise/Conversion	+3,475 sh	—	—	3,475
2013-06-07	LFCRLIFECORE BIOMEDICAL, INC. \DE\ · Restricted Stock Unit (RSU)M Exercise/Conversion	Director	MExercise/Conversion	+3,496 sh	—	—	3,496
2013-05-16	LFCRLIFECORE BIOMEDICAL, INC. \DE\M Exercise/Conversion	Director	MExercise/Conversion	+1,667 sh	—	—	10,001
2013-05-16	LFCRLIFECORE BIOMEDICAL, INC. \DE\ · Restricted Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	−1,667 sh	—	—	0
2012-05-23	LFCRLIFECORE BIOMEDICAL, INC. \DE\ · Restricted Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	−1,667 sh	—	—	0
2012-05-23	LFCRLIFECORE BIOMEDICAL, INC. \DE\M Exercise/Conversion	Director	MExercise/Conversion	+1,667 sh	—	—	8,334
2012-05-16	LFCRLIFECORE BIOMEDICAL, INC. \DE\ · Stock Option (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	+5,000 sh	$6.66	+$33.3K	30,000
2012-05-16	LFCRLIFECORE BIOMEDICAL, INC. \DE\ · Restricted Stock Unit (RSU)M Exercise/Conversion	Director	MExercise/Conversion	+1,667 sh	—	—	1,667
2011-12-11	LFCRLIFECORE BIOMEDICAL, INC. \DE\ · Restricted Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	−3,333 sh	—	—	0
2011-12-11	LFCRLIFECORE BIOMEDICAL, INC. \DE\M Exercise/Conversion	Director	MExercise/Conversion	+3,333 sh	$5.64	+$18.8K	6,667
2011-08-03	ACCELRYS, INC.A Award	Director	AAward	+6,000 sh	—	—	6,000
2011-05-26	LFCRLIFECORE BIOMEDICAL, INC. \DE\M Exercise/Conversion	Director	MExercise/Conversion	+1,667 sh	—	—	1,667
2011-05-26	LFCRLIFECORE BIOMEDICAL, INC. \DE\ · Restricted Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	−1,667 sh	—	—	0
2011-05-23	LFCRLIFECORE BIOMEDICAL, INC. \DE\ · Restricted Stock Unit (RSU)M Exercise/Conversion	Director	MExercise/Conversion	+1,667 sh	—	—	1,667
2011-05-23	LFCRLIFECORE BIOMEDICAL, INC. \DE\ · Stock Option (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	+5,000 sh	$5.77	+$28.8K	25,000
2010-08-03	ACCELRYS, INC.A Award	Director	AAward	+18K sh	—	—	18,000
2010-07-01	ACCELRYS, INC.Non-Qualified Stock Option (right to buy)A Award	Director	AAward	+9,752 sh	—	—	9,752
2010-07-01	ACCELRYS, INC.Non-Qualified Stock Option (right to buy)A Award	Director	AAward	+9,752 sh	—	—	9,752
2010-07-01	ACCELRYS, INC.A Award	Director	AAward	+48.6K sh	—	—	48,641
2010-07-01	ACCELRYS, INC.Non-Qualified Stock Option (right to buy)A Award	Director	AAward	+9,752 sh	—	—	9,752
2010-07-01	ACCELRYS, INC.Non-Qualified Stock Option (right to buy)A Award	Director	AAward	+39K sh	—	—	39,010
2010-07-01	ACCELRYS, INC.Non-Qualified Stock Option (right to buy)A Award	Director	AAward	+39K sh	—	—	39,010

Recent filings

Accepted (ET)
May 304/A
GOLDBY STEVEN D0001628280-19-007416
SEC(opens sec.gov)
May 284
GOLDBY STEVEN D0001628280-19-007230
SEC(opens sec.gov)
Feb 284
GOLDBY STEVEN D0001437749-19-003666
SEC(opens sec.gov)
Jan 104
GOLDBY STEVEN D0001437749-19-000633
SEC(opens sec.gov)
Jun 14
GOLDBY STEVEN D0001437749-18-011100
SEC(opens sec.gov)
May 254
GOLDBY STEVEN D0001437749-18-010773
SEC(opens sec.gov)
Feb 274
GOLDBY STEVEN D0001437749-18-003431
SEC(opens sec.gov)
Jun 54
LANDEC CORP \CA\0001437749-17-010671
SEC(opens sec.gov)
May 264
LANDEC CORP \CA\0001437749-17-010191
SEC(opens sec.gov)
May 244
LANDEC CORP \CA\0001437749-17-009977
SEC(opens sec.gov)

Companies

Address

3340 HILLVIEW AVENUE C/O VENROCK

PALO ALTO, CA, 94304